Provided by Tiger Trade Technology Pte. Ltd.

Travere Therapeutics, Inc.

62.76
-1.9800-3.06%
Post-market: 62.760.00000.00%19:51 EDT
Volume:2.24M
Turnover:140.91M
Market Cap:5.92B
PE:-131.72
High:64.89
Open:64.89
Low:62.47
Close:64.74
52wk High:68.73
52wk Low:22.06
Shares:94.26M
Float Shares:92.77M
Volume Ratio:1.44
T/O Rate:2.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4764
EPS(LYR):-0.2864
ROE:-236.35%
ROA:-3.73%
PB:241.25
PE(LYR):-219.17

Loading ...

Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 17, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Major Issues Report

Form 8-K - Current report
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

Major Issues Report

Form 8-K - Current report